Truqap Plus Faslodex Recommended for EU Approval in Advanced Breast Cancer Treatment
AstraZeneca’s Combination Therapy Shows Significant Efficacy in Phase III Trial Cambridge, UK- On Monday, AstraZeneca’s combination of Truqap (capivasertib) with Faslodex (fulvestrant) received a recommendation for approval from the Committee…